Profound Medical Corp. Files Material Change Report
Ticker: PROF · Form: 6-K · Filed: Dec 16, 2024 · CIK: 1628808
| Field | Detail |
|---|---|
| Company | Profound Medical Corp. (PROF) |
| Form Type | 6-K |
| Filed Date | Dec 16, 2024 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-change, 6-k, regulatory-filing
TL;DR
Profound Medical Corp. just dropped a material change report, gotta see what's up.
AI Summary
Profound Medical Corp. filed a Form 6-K on December 16, 2024, to report a Material Change. The filing incorporates by reference Exhibit 99.1, a Material Change Report dated December 16, 2024. The company is based in Mississauga, Ontario, Canada.
Why It Matters
This filing indicates a significant event or development for Profound Medical Corp. that is material to investors, requiring public disclosure.
Risk Assessment
Risk Level: medium — Material change reports can signal significant positive or negative developments, requiring further investigation to assess the impact.
Key Players & Entities
- Profound Medical Corp. (company) — Registrant
- December 16, 2024 (date) — Filing and Report Date
- Mississauga, Ontario (location) — Company Headquarters
- Exhibit 99.1 (document) — Attached Material Change Report
FAQ
What is the specific nature of the material change reported by Profound Medical Corp.?
The filing does not specify the nature of the material change; it only states that Exhibit 99.1, a Material Change Report dated December 16, 2024, is attached.
When was this Form 6-K filed with the SEC?
This Form 6-K was filed on December 16, 2024.
What is Profound Medical Corp.'s principal executive office address?
The principal executive office is located at 2400 Skymark Avenue, Unit 6, Mississauga, Ontario L4W 5K5.
Does Profound Medical Corp. file annual reports under Form 20-F or Form 40-F?
The filing indicates that Profound Medical Corp. files under Form 40-F.
What is the SEC file number for Profound Medical Corp.?
The SEC file number is 001-39032.
Filing Stats: 161 words · 1 min read · ~1 pages · Grade level 13.1 · Accepted 2024-12-16 16:05:41
Filing Documents
- tm2431199d1_6k.htm (6-K) — 7KB
- tm2431199d1_ex99-1.htm (EX-99.1) — 17KB
- 0001104659-24-128894.txt ( ) — 26KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. PROFOUND MEDICAL CORP. (Registrant) Date: December 16, 2024 /s/ Rashed Dewan Rashed Dewan Chief Financial Officer